Search Result "SAHA-based inhibitors"
Synergistic Effect of the Combination of Novel Suberoylanilide Hydroxamic Acid Derivatives with Cisplatin on Anti-proliferation of Human Cancer Cells
Journal: Medicinal Chemistry
Volume: 12 Issue: 8 Year: 2016 Page: 767-774
Author(s): Rui Xie,Jinghua Shi,Chunhui Cheng,Fan Yun,Xia Liu,Pingwah Tang,Xinying Wu,Ming Yang,Qipeng Yuan
Synthesis and Anti-tumor Activities of Novel Phenyl Substituted Suberoylanilide Hydroxamic Acid Derivatives Against Human Cancer Cells
Journal: Medicinal Chemistry
Volume: 11 Issue: 7 Year: 2015 Page: 636-648
Author(s): Rui Xie,Jinghua Shi,Yue Qu,Pingwah Tang,Xinying Wu,Ming Yang,Qipeng Yuan
5-Aryl-1,3,4-Thiadiazole-Based Hydroxamic Acids as Histone Deacetylase Inhibitors and Antitumor Agents: Synthesis, Bioevaluation and Docking Study
Journal: Medicinal Chemistry
Volume: 11 Issue: 3 Year: 2015 Page: 296-304
Author(s): Tran Thi Lan Huong, Do Thi Mai Dung, Dao Thi Kim Oanh, Tran Thi Bich Lan, Phan Thi Phuong Dung, Vu Duc Loi, Kyung Rok Kim, Byung Woo Han, Jieun Yun, Jong Soon Kang, Youngsoo Kim, Sang-Bae Han, Nguyen-Hai Nam
A Structural Insight into Hydroxamic Acid Based Histone Deacetylase Inhibitors for the Presence of Anticancer Activity
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 23 Year: 2014 Page: 2642-2664
Author(s): H. Rajak,A. Singh,K. Raghuwanshi,R. Kumar,P.K. Dewangan,R. Veerasamy,P.C. Sharma,A. Dixit,P. Mishra
Novel 3-substituted-2-oxoindoline-based N-hydroxypropenamides as Histone Deacetylase Inhibitors and Antitumor Agents
Journal: Medicinal Chemistry
Volume: 11 Issue: 8 Year: 2015 Page: 725-735
Author(s): Do T. M. Dung,Phan T. P. Dung,Dao T. K. Oanh,Pham T. Hai,Le T. T. Huong,Vu D. Loi,Hyunggu Hahn,Byung W. Han,Jisung Kim,Sang-Bae Han,Nguyen-Hai Nam
Histone Deacetylase Inhibitors: Recent Insights from Basic to Clinical Knowledge & Patenting of Anti-Cancer Actions
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 6 Issue: 1 Year: 2011 Page: 131-145
Author(s): Vincenzo Carafa, Angela Nebbioso, Lucia Altucci
Synergistic Combination of Histone Deacetylase Inhibitor Suberoylanilide Hydroxamic Acid and Natural Flavonoid Curcumin Exhibits Anticancer and Antibacterial Activity
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 21 Issue: 10 Year: 2021 Page: 1301-1308
Author(s): Ergül M. Altundağ,Kübra Toprak,Gizem Şanlıtürk,Mümtaz Güran,Cahit Ãzbilenler,Namık R. Kerküklü,Ayşe M. Yılmaz,Ahmet S. Yalçın
Pharmacological Characterization of Histone Deacetylase Inhibitor and Tumor Cell-Growth Inhibition Properties of New Benzofuranone Compounds
Journal: Current Cancer Drug Targets
Volume: 11 Issue: 8 Year: 2011 Page: 919-928
Author(s): C. Blanquart, M. Francois, C. Charrier, P. Bertrand, M. Gregoire
Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Journal: Current Drug Metabolism
Volume: 8 Issue: 4 Year: 2007 Page: 383-394
Author(s): V. Santini, A. Gozzini, G. Ferrari
Novel Suberoylanilide Hydroxamic Acid Analogs Inhibit Angiogenesis and InduceApoptosis in Breast Cancer Cells
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 5 Year: 2022 Page: 914-925
Author(s): Amber Vyas,Vijay S. Madamsetty,Soumen Saha,Chaitanya C. Gali,Venu Yakati,Swathi Vangala,Gopikrishna Moku